{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T00:00:55Z","timestamp":1794960055332,"version":"4.9.1"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","license":[{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Polish Ministry of Science and Higher Education","award":["S247\/17"],"award-info":[{"award-number":["S247\/17"]}]},{"name":"Polish Ministry of Science and Higher Education","award":["S167\/18"],"award-info":[{"award-number":["S167\/18"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:sec>\n                    <jats:title>Background.<\/jats:title>\n                    <jats:p>Data on the course of Epstein-Barr virus (EBV) DNAemia are limited in the pediatric liver transplant (LT) setting. This study aims to analyze the kinetics and clinical outcomes of EBV DNAemia in whole blood (WB) and plasma, and to evaluate the incidence and risk factors for EBV DNAemia, chronic high EBV load (CHL) carriage, and posttransplant lymphoproliferative disorder (PTLD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods.<\/jats:title>\n                    <jats:p>A retrospective analysis of longitudinal EBV DNAemia and clinical data from 237 children undergoing LT between April 2014 and May 2022 was performed. EBV DNAemia was measured in WB, switching to plasma on September 1, 2018. There was a 20-mo transitional period, during which both matrices were used.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results.<\/jats:title>\n                    <jats:p>\n                      CHL occurred in 23 (22.1%) patients monitored in WB. Peak EBV DNAemia and EBV DNAemia exposure (measured as the area under the concentration-time curve) &gt;1 y post-LT were higher in PTLD cases, regardless of the matrix used. Among CHL carriers, 21.7% (5\/23) developed PTLD. In age-adjusted analyses, cytomegalovirus (CMV) DNAemia within 1 y post-LT was associated with EBV DNAemia (relative risk [RR], 1.16;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u20050.026). CHL carriage was associated with CMV DNAemia within 1 y post-LT (RR, 2.33;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u20050.044), EBV donor-positive\/recipient-negative (D+\/R\u2013: RR, 3.62;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u20050.036), ABO-incompatible graft (RR, 3.03;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u20050.001), and early EBV DNAemia (&lt;6 mo: RR, 3.46;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u20050.030). PTLD development was associated with early EBV DNAemia (&lt;6 mo: RR, 3.58;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u20050.022) and CMV D+\/R\u2013 (RR, 2.49;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u20050.030).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions.<\/jats:title>\n                    <jats:p>The study provides longitudinal data on EBV DNAemia in the context of CHL and PTLD. Prospective studies are warranted to validate the identified factors associated with EBV-related outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/tp.0000000000005767","type":"journal-article","created":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T20:00:30Z","timestamp":1780603230000},"page":"e1485-e1499","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Kinetics and Clinical Outcomes of EBV DNAemia in Whole Blood and Plasma Among Pediatric Liver Transplant Recipients: A Single-center Experience"],"prefix":"10.1097","volume":"110","author":[{"given":"Beata","family":"Kasztelewicz","sequence":"first","affiliation":[{"name":"Department of Clinical Microbiology and Immunology, The Children\u2019s Memorial Health Institute, Warsaw, Poland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Skrok","sequence":"additional","affiliation":[{"name":"Department of Clinical Microbiology and Immunology, The Children\u2019s Memorial Health Institute, Warsaw, Poland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irena","family":"Jankowska","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Hepatology, Nutritional Disorders and Pediatrics, The Children\u2019s Memorial Health Institute, Warsaw, Poland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Kalici\u0144ski","sequence":"additional","affiliation":[{"name":"Department of Pediatric Surgery and Organ Transplantation, The Children\u2019s Memorial Health Institute, Warsaw, Poland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorota","family":"Broniszczak-Czyszek","sequence":"additional","affiliation":[{"name":"Department of Pediatric Surgery and Organ Transplantation, The Children\u2019s Memorial Health Institute, Warsaw, Poland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaudia","family":"Lenarczyk","sequence":"additional","affiliation":[{"name":"Department of Clinical Microbiology and Immunology, The Children\u2019s Memorial Health Institute, Warsaw, Poland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Dzier\u017canowska-Fangrat","sequence":"additional","affiliation":[{"name":"Department of Clinical Microbiology and Immunology, The Children\u2019s Memorial Health Institute, Warsaw, Poland."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,6,4]]},"reference":[{"key":"R1-20260616","doi-asserted-by":"crossref","first-page":"e13652","DOI":"10.1111\/ctr.13652","article-title":"Post-transplant lymphoproliferative disorders, Epstein-Barr virus infection, and disease in solid organ transplantation: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.","volume":"33","author":"Allen","year":"2019","journal-title":"Clin Transplant"},{"key":"R2-20260616","doi-asserted-by":"crossref","first-page":"e14471","DOI":"10.1111\/petr.14471","article-title":"The IPTA Nashville Consensus Conference on Post-Transplant lymphoproliferative disorders after solid organ transplantation in children: III\u2014consensus guidelines for Epstein-Barr virus load and other biomarker monitoring.","volume":"28","author":"Preiksaitis","year":"2024","journal-title":"Pediatr Transplant"},{"key":"R3-20260616","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1034\/j.1399-3062.2001.003002079.x","article-title":"Epstein-Barr virus load monitoring: its role in the prevention and management of post-transplant lymphoproliferative disease.","volume":"3","author":"Rowe","year":"2001","journal-title":"Transpl Infect Dis"},{"key":"R4-20260616","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1399-3046.2008.00926.x","article-title":"Chronic high Epstein-Barr viral load carriage in pediatric liver transplant recipients.","volume":"13","author":"Green","year":"2009","journal-title":"Pediatr Transplant"},{"key":"R5-20260616","doi-asserted-by":"crossref","first-page":"e13147","DOI":"10.1111\/petr.13147","article-title":"Epidemiology and outcome of chronic high Epstein-Barr viral load carriage in pediatric kidney transplant recipients.","volume":"22","author":"Yamada","year":"2018","journal-title":"Pediatr Transplant"},{"key":"R6-20260616","doi-asserted-by":"crossref","first-page":"e12943","DOI":"10.1111\/petr.12943","article-title":"Two sides of the Epstein-Barr virus (EBV) coin: long-term control of EBV after liver transplantation?","volume":"21","author":"Yamada","year":"2017","journal-title":"Pediatr Transplant"},{"key":"R7-20260616","doi-asserted-by":"crossref","first-page":"1335496","DOI":"10.3389\/fped.2024.1335496","article-title":"Chronic Epstein-Barr viral load carriage after pediatric organ transplantation.","volume":"12","author":"Yamada","year":"2024","journal-title":"Front Pediatr"},{"key":"R8-20260616","doi-asserted-by":"crossref","first-page":"e12875","DOI":"10.1111\/petr.12875","article-title":"Epstein-Barr virus DNA monitoring in serum and whole blood in pediatric liver transplant recipients who do or do not discontinue immunosuppressive therapy.","volume":"21","author":"Kullberg-Lindh","year":"2017","journal-title":"Pediatr Transplant"},{"key":"R9-20260616","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1097\/TP.0000000000004429","article-title":"Early detection of Epstein-Barr virus as a risk factor for chronic high Epstein-Barr viral load carriage at a living-donor-dominant pediatric liver transplantation center.","volume":"107","author":"Yamada","year":"2023","journal-title":"Transplantation"},{"key":"R10-20260616","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jcv.2011.11.010","article-title":"Comparison of six different specimen types for Epstein-Barr viral load quantification in peripheral blood of pediatric patients after heart transplantation or after allogeneic hematopoietic stem cell transplantation.","volume":"53","author":"Ruf","year":"2012","journal-title":"J Clin Virol"},{"key":"R11-20260616","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/j.1399-3062.2008.00313.x","article-title":"Comparison of serum and whole blood levels of cytomegalovirus and Epstein-Barr virus DNA.","volume":"10","author":"Kullberg-Lindh","year":"2008","journal-title":"Transpl Infect Dis"},{"key":"R12-20260616","doi-asserted-by":"crossref","first-page":"e70042","DOI":"10.1111\/tid.70042","article-title":"Incidence and timing of Epstein-Barr virus whole blood DNAemia in Epstein-Barr virus-mismatched adult and pediatric solid organ transplant recipients.","volume":"27","author":"Burton","year":"2025","journal-title":"Transpl Infect Dis"},{"key":"R13-20260616","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1182\/blood-2015-09-672030","article-title":"The clinical significance of EBV DNA in the plasma and peripheral blood mononuclear cells of patients with or without EBV diseases.","volume":"127","author":"Kanakry","year":"2016","journal-title":"Blood"},{"key":"R14-20260616","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1097\/00007890-200109270-00006","article-title":"Patients at risk for development of posttransplant lymphoproliferative disorder: plasma versus peripheral blood mononuclear cells as material for quantification of Epstein-Barr viral load by using real-time quantitative polymerase chain reaction.","volume":"72","author":"Wagner","year":"2001","journal-title":"Transplantation"},{"key":"R15-20260616","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1399-3062.2011.00656.x","article-title":"Epstein-Barr virus DNA load in peripheral blood mononuclear cells and whole blood from pediatric transplant recipients.","volume":"13","author":"Kasztelewicz","year":"2011","journal-title":"Transpl Infect Dis"},{"key":"R16-20260616","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.ijsu.2014.07.013","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.","volume":"12","author":"von Elm","year":"2014","journal-title":"Int J Surg"},{"key":"R17-20260616","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1097\/TP.0000000000004919","article-title":"Mechanistic understanding of EBV+lymphoproliferative disease development after transplantation.","volume":"108","author":"Furlano","year":"2024","journal-title":"Transplantation"},{"key":"R18-20260616","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/j.1399-3046.2009.01258.x","article-title":"The changing face of post-transplant lymphoproliferative disease in the era of molecular EBV monitoring.","volume":"14","author":"Kerkar","year":"2010","journal-title":"Pediatr Transplant"},{"key":"R19-20260616","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1097\/PAS.0000000000000282","article-title":"EBV-positive mucocutaneous ulcer in organ transplant recipients: a localized indolent posttransplant lymphoproliferative disorder.","volume":"38","author":"Hart","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"R20-20260616","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1399-3046.2008.00965.x","article-title":"Unusual case of Epstein-Barr virus DNA tissue positive: blood negative in a patient with post-transplant lymphoproliferative disorder.","volume":"13","author":"Levenson","year":"2009","journal-title":"Pediatr Transplant"},{"key":"R21-20260616","doi-asserted-by":"crossref","first-page":"5854","DOI":"10.4049\/jimmunol.1001024","article-title":"EBV-specific CD8+ T cells from asymptomatic pediatric thoracic transplant patients carrying chronic high EBV loads display contrasting features: activated phenotype and exhausted function.","volume":"186","author":"Macedo","year":"2011","journal-title":"J Immunol"},{"key":"R22-20260616","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/petr.12156","article-title":"Increased levels of PD-1 expression on CD8 T cells in patients post-renal transplant irrespective of chronic high EBV viral load.","volume":"17","author":"Moran","year":"2013","journal-title":"Pediatr Transplant"},{"key":"R23-20260616","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.ajt.2023.05.007","article-title":"Distinct association between chronic Epstein-Barr virus infection and T cell compartments from pediatric heart, kidney, and liver transplant recipients.","volume":"23","author":"Yamada","year":"2023","journal-title":"Am J Transplant"},{"key":"R24-20260616","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/TP.0b013e3181aacdd7","article-title":"The impact of EBV load on T-cell immunity in pediatric thoracic transplant recipients.","volume":"88","author":"Macedo","year":"2009","journal-title":"Transplantation"},{"key":"R25-20260616","first-page":"S31","article-title":"A focused review of Epstein-Barr virus infections and PTLD in pediatric transplant recipients: guidance from the IPTA and ECIL guidelines.","volume":"13","author":"Yamada","year":"2024","journal-title":"J"},{"key":"R26-20260616","doi-asserted-by":"crossref","first-page":"e13977","DOI":"10.1111\/tid.13977","article-title":"Cytomegalovirus in the transplant setting: where are we now and what happens next? A report from the international CMV symposium 2021.","volume":"24","author":"Kotton","year":"2022","journal-title":"Transpl Infect Dis"},{"key":"R27-20260616","doi-asserted-by":"crossref","first-page":"e14763","DOI":"10.1111\/petr.14763","article-title":"Epstein-Barr virus-associated post-transplant lymphoproliferative disorders in pediatric transplantation: a prospective multicenter study in the United States.","volume":"28","author":"Tajima","year":"2024","journal-title":"Pediatr Transplant"},{"key":"R28-20260616","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.transproceed.2010.02.042","article-title":"Risk factors for posttransplant lymphoproliferative disorder in pediatric liver transplant recipients with cytomegalovirus antigenemia.","volume":"42","author":"Kim","year":"2010","journal-title":"Transplant Proc"},{"key":"R29-20260616","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1093\/clinids\/20.5.1346","article-title":"Pretransplantation assessment of the risk of lymphoproliferative disorder.","volume":"20","author":"Walker","year":"1995","journal-title":"Clin Infect Dis"},{"key":"R30-20260616","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/j.1600-6143.2007.02080.x","article-title":"Chronic high Epstein-Barr viral load state and risk for late-onset posttransplant lymphoproliferative disease\/lymphoma in children.","volume":"8","author":"Bingler","year":"2008","journal-title":"Am J Transplant"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000005767","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:00:39Z","timestamp":1781647239000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000005767"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,4]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000005767","relation":{},"ISSN":["0041-1337","1534-6080"],"issn-type":[{"value":"0041-1337","type":"print"},{"value":"1534-6080","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,4]]}}}